Navigation Links
AGA presents cutting-edge research during DDW
Date:4/30/2010

Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week 2010 (DDW), the largest and most prestigious gastroenterology meeting, from May 1 to May 5, 2010, at the Ernest N. Morial Convention Center, New Orleans, LA. DDW is the annual meeting of the American Gastroenterological Association (AGA) Institute, the largest and oldest GI society in the world. AGA researchers will present exciting, cutting-edge data during the meeting that will help change the way physicians diagnose and treat GI disorders.

All data presented during DDW is embargoed until the beginning of the presentation or an official DDW press conference, whichever occurs first. Go to www.ddw.org for a list of press conferences.

Late-Breaking Session

On Tuesday, May 4 from 2:15 to 3:45 p.m. CT, Ballroom C, the AGA will feature its late-breaking clinical abstracts, which include exciting data on:

  • A Randomized Placebo-controlled Trial of MDX-1100, an Anti-IP-10 Antibody, for Moderately-to-Severely Active Ulcerative Colitis. L. Mayer et al. (2:15 p.m.)
  • Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide plus Peginterferon and Ribavirin in Nave Patients with Chronic Hepatitis C Genotype 1 Infection: Final Report. B. Bacon et al. (2:30 p.m.)
  • Randomized Clinical Trial in Clostridium difficile Infection Confirms Superiority of Fidaxomicin over Vancomycin. S. Johnson et al. (2:45 p.m.)
  • Prospective Clinical Validation of an Assay for Methylated SEPT9 DNA in Human Plasma as a Colorectal Cancer Screening Tool in Average Risk Men and Women 50 Years and Older. T. Church et al. (3:00 p.m.)
  • A Prospective, Multicentre Study to Evaluate a Novel Non-Endoscopic Screening Device for Barrett's Esophagus in the Community Setting. S. Kadri et al. (3:15 p.m.)
  • Multi-Modality Endoscopic Therapy for Complete Eradication of Barrett's Esophagus. N. Gupta et al. (3:30 p.m.)

Plenary Sessions

During the Presidential Plenary Session, AGA Institute President, Gail A. Hecht, MD, MS, AGAF, will focus on critical questions for gastroenterology. Two concurrent plenary sessions feature noteworthy clinical and basic science research presented at DDW.

The Presidential Plenary session presentations (Monday, May 3, 10 a.m. to noon CT, Auditorium AB) include:

  • Celiac Disease Therapy and Novel Approaches. C. Kelly (10:09 a.m.)
  • Evaluating IBD: Outcomes and Complications. M. Abreu (10:19 a.m.)
  • Major Advances in IBS. L. Chang (10:29 a.m.)
  • Eosinophilic Esophagitis: Challenges and Horizons. G. Furuta (10:39 a.m.)
  • Gastric Disease in the 21st Century: A Tale of Three Stomachs. T. Wang (10:49 a.m.)
  • Microbiota in Digestive Health Promise, Prospects and Pragmatism. F. Shanahan (10:59 a.m.)
  • Obesity and Bariatrics for the Endoscopist: New Techniques. C. Thompson (11:09 a.m.)
  • Medical Management of NAFLD. A. Diehl (11:19 a.m.)
  • Era of Health-care Reform: What Is the Impact on GI? J. Inadomi (11:29 a.m.)

The Clinical Plenary session presentations (Monday, May 3, 8 to 10 a.m. CT, Auditorium AB) include:

  • UK Flexible Sigmoidoscopy Screening Trial: Colorectal Cancer Incidence and Mortality Rates at 11 Years After a Single Screening Examination. W. Atkin et al. (8:05 a.m.)
  • Laparoscopic Antireflux Surgery vs Long-Term Esomeprazole Treatment for Chronic GERD. Final Results After 5 Yrs of Follow up in the Lotus Study. J.P. Galmiche et al. (8:20 a.m.)
  • The European Achalasia Trial: A Randomized Multi-Centre Trial Comparing Endoscopic Pneumodilation and Laparoscopic Myotomy As Primary Treatment of Idiopathic Achalasia. G. Boeckxstaens et al. (8:35 a.m.)
  • Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials. A. Lembo et al. (8:50 a.m.)

The Basic Science Plenary session presentations (Monday, May 3, 8 to 10 a.m. CT, Room 393-396) include:

  • Altered Gut Microbiota in Toll-Like Receptor-5 (TLR5) Deficient Mice Results in Metabolic Syndrome. M. Vijay-Kumar et al. (8:05 a.m.)
  • Leptin Resistance in Vagal Afferent Neurons Leads to Decreased Cholecystokinin Signaling in Diet-Induced Obese Rats. G. de Lartigue et al. (8:22 a.m.)
  • Regulation of Food Intake in Diet-Induced Obesity. L. Kaplan (8:39 a.m.)
  • Characterization of Slowly Cycling Telomerase-Expressing Intestinal Stem Cells. C. Richmond et al. (9:04 a.m.)
  • The Crohn's Disease Protective SNP Rs11209026 Allele "a" Mediates Alternative Splicing in Human IL23R Transcription. R. Yu et al. (9:21 a.m.)

Other exciting data will be presented during DDW, including 36 clinical symposia, 11 translational symposia, 14 research symposia and eight state-of-the-art lectures on a range of GI topics. Additionally, the AGA Institute will sponsor eight curbside consultant sessions. Eight focused research roundtables and 14 focused clinical updates breakfast sessions designed to help participants choose the must-see basic science and clinical research abstracts presented during DDW will occur throughout the meeting.

AGA Digestive Health Outcomes Registry

DDW marks the launch of the AGA Digestive Health Outcomes Registry, a revolutionary national outcomes-driven registry. It allows gastroenterologists to monitor and improve patient care, while also generating data to compare the efficacy of treatments and potentially increase reimbursement. The AGA Registry launches with an initial focus on IBD and colorectal cancer prevention.

On Wednesday, May 5, from 8:30 to 10 a.m., the physicians who created the registry will lead a session in rooms 280-282 to cover topics, including what is a data registry and why participate, limits and potential pitfalls of a data registry, registry reports, and how registries can impact public health of underrepresented populations.

ROME Foundation-AGA Institute Lectureship

Erwin G. Zoetendal, MD, assistant professor in the agrotechnology and food sciences laboratory of microbiology at Wageningen University, the Netherlands, will shed light on the mysteries of gut microbiota as the invited lecturer during Tuesday's third annual Rome Foundation-AGA Institute Lectureship (10:30 to 11:30 a.m. CT, Room 391/392). His talk, "Understanding Gut Microbiota: A New Era in Gastroenterology," will provide an overview of gastrointestinal tract microbiota diversity by discussing culture-independent approaches to study microbiota diversity in relation to health and disease including functional gastrointestinal disorders as well as culture-independent approaches to study microbiota genetic potential and activity.

Douglas Drossman, MD, AGAF, Rome Foundation president, said the Rome Foundation and the AGA Institute are honored to have Dr. Zoetendal present this year's lecture. "There are huge numbers of bacteria living in harmony within every human organism. And this is the guy who understands best how different types affect the gut inside and out. He is a translational scientist who will help our members better understand when to use probiotics and when not to."


'/>"/>

Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Nautilus IDScan.net Presents New Drivers' License Parsing Component, a Magic Tool for Software Developers
2. CNBC.com Presents "Marijuana & Money"
3. BestofNorthCarolina.com Presents Their Inaugural 'Carolina Beach Bash' to Benefit the Juvenile Diabetes Research Foundation
4. Morehead Presents Webinar on “When Engagement Isn't Enough: Retaining RNs”
5. Atlanta Group Presents Issues in Business Psychology at National Conference
6. PDA Presents the Facts on Braces
7. Researcher presents risk-free treatment for low female sexual desire
8. Welsh Tree LLC Proudly Presents the Release of the Celtic Pathways CD by Jason Evans, in Time for Saint Patrick's Day
9. Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
10. Keynote Speaker Presents Top Business Plan For Internal Communication Through Social Media
11. Targeting leukemia cells gene addiction presents new strategy for treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
Breaking Medicine Technology: